论文部分内容阅读
本文对体外反搏治疗老年心脑血管病33例进行了分析。体外反搏组和对照(药疗)组治疗心绞痛在缓解症状、改善心电图方面无显著差异, 平均显效时间前者短于后者。提示体外反搏和药物治疗,在临床上相互配合为宜,以缩疗程,提高疗效。尤其适用于冠心病中常见的稳定劳力型心绞痛、病态窦房结综合征,其“阿托品试验”转除率为33.3%。体外反搏与药物治疗脑血栓总有效率均为100%,显效率二者有显著差异,体外反搏对改善运动性失语、精神症状、智能障碍及促进舌、面瘫恢复的功效优于川芎嗪。对川芎嗪治疗未愈的病例仍可选用体外反搏,并适用于脑动脉硬化性痴呆。对于椎-基动脉供血不足之疗效,从治疗小卒中以预防大卒中的观点,认为亦有临床实用价值。
In this paper, EECP treatment of 33 cases of elderly cardiovascular and cerebrovascular disease were analyzed. EECP group and control group (treatment group) in the treatment of angina pectoris, to improve the ECG was no significant difference, the average effective time was shorter than the former. Tip extracorporeal counterpulsation and drug therapy, in clinical cooperation is appropriate to reduce the shrinkage process to improve efficacy. Especially for coronary heart disease in common stable angina pectoris, sick sinus syndrome, the “atropine test” removal rate was 33.3%. EECP and drug treatment of cerebral thrombosis total effective rate was 100%, the significant difference between the two significant differences in vitro counterpulsation to improve motor aphasia, mental symptoms, mental retardation and to promote the recovery of tongue and facial palsy better than tetramethylpyrazine . Tetramethylpyrazine treatment of non-healing cases can still use the EECP and applied to cerebral arteriosclerosis dementia. For vertebrobasilar insufficiency, from the treatment of stroke to prevent stroke point of view, that there are clinical practical value.